Only two plasma-to-autopsy studies conducting head-to-head comparisons of p-tau epitopes for the detection of AD neuropathology have been published [24, 25], but they examine two to three p-tau variants using immunoassays, which require separate sample preparation and analysis for each targeted epitope. Here, MAPT is linked to Alzheimer disease.